Psyence Biomedical Ltd (PBM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 03-2025 | 09-2024 | 03-2024 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,993 | N/A | 2,961 | -51,159 | -1,606 |
| Depreciation Amortization | 3 | N/A | 2 | 0 | N/A |
| Other Working Capital | 207 | N/A | 186 | -1,173 | 54 |
| Other Operating Activity | -246 | 0 | -4,664 | 49,387 | -35 |
| Operating Cash Flow | $-2,029 | $N/A | $-1,516 | $-2,945 | $-1,588 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | N/A | -6 | -6 | N/A |
| Other Investing Activity | -4,011 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-4,012 | $N/A | $-6 | $-6 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,000 | N/A | 715 |
| Other Financing Activity | 7,055 | 0 | 1,722 | 2,350 | 144 |
| Financing Cash Flow | $7,055 | $N/A | $2,722 | $2,350 | $859 |
| Beginning Cash Position | 6,135 | N/A | 733 | 1,334 | 1,334 |
| End Cash Position | 7,150 | N/A | 1,933 | 733 | 606 |
| Net Cash Flow | $1,015 | $N/A | $1,199 | $-601 | $-729 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,029 | N/A | -1,516 | -2,945 | -1,588 |
| Capital Expenditure | 0 | N/A | -6 | N/A | N/A |
| Free Cash Flow | -2,029 | 0 | -1,522 | -2,945 | -1,588 |